[250 Pages Report] The global neuro monitoring system market size is anticipated to be valued at US$ 9.4 Billion in 2032. An increasing number of critical and complex surgeries across the globe is set to propel the neuro-monitoring system market in the upcoming years. According to FMI, demand for neuro-monitoring systems is likely to reach US$ 3.1 Billion in 2022 and exhibit steady growth at 6.8% CAGR in the forecast period from 2022 to 2032.
| Report Attribute | Details |
|---|---|
| Neuro Monitoring System Market Estimated Base Year Value (2021) | US$ 2.5 Billion |
| Neuro Monitoring System Market Expected Market Value (2022) | US$ 3.1 Billion |
| Neuro Monitoring System Market Anticipated Forecast Value (2032) | US$ 9.4 Billion |
| Neuro Monitoring System Market Projected Growth Rate (2022 to 2032) | 6.8% CAGR |
Neuro monitoring or nerve monitoring systems are considered to be novel techniques that can lower the risk of neurological defects after surgeries take place. These are associated with those surgeries that can negatively affect the nervous system.
Sales of neuromonitoring systems are expected to surge in future years owing to their ability to reduce the risk of paralysis, hearing loss, and muscle weakness. These systems are also capable of upgrading the outcomes amid a spinal surgery, increasing safety, and delivering immediate feedback.
Besides, neuro-monitoring systems can measure electrically evoked signals from the nerves to provide real-time information about their activities. These are considered to be ideal for preventing severe damage to the nervous system.
Various educational and research institutions are anticipated to conduct more R&D activities to discover new techniques. In May 2022, for instance, the Montreal Neurological Institute and Hospital recruited 70 medical students for performing virtual brain tumour removals.
They had to do it on a neurosurgical simulator and were provided with instructions from a remote expert instructor or AI tutor. Similar other innovations in the neuro-monitoring system market are likely to drive growth.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Demand for neuromonitoring systems is likely to grow at a fast pace on the back of the rising prevalence of chronic diseases. The increasing number of road accidents is another major factor that is estimated to augur well for the market. Also, increasing awareness among doctors regarding the benefits of neuro-monitoring systems is expected to propel the market.
As these systems are capable of assessing the correct placement screws during surgeries, these can prevent the risk of nerve intrusion. At the same time, these can monitor the parts of the spinal cord that can further assist in the detection of sensory changes in an individual’s body.
The lack of knowledge about the availability of numerous cutting-edge healthcare devices, especially in underdeveloped countries is projected to hamper the expansion of the neuro-monitoring system market size. Also, these systems require high initial installation costs, which may not be feasible for small-scale enterprises based in emerging economies. This factor may also obstruct the market in the evaluation period.
Principal Consultant
In terms of region, North America is likely to remain at the forefront by accounting for the largest neuro-monitoring system market share in the upcoming years. This growth is attributable to the robust presence of various prominent healthcare device manufacturers in the U.S. and Canada. The availability of well-established healthcare infrastructure in these countries is another crucial factor that is estimated to augment growth.
In addition to that, the large patient population suffering from chronic diseases is set to contribute to this growth. The rising number of clinical trials conducted by research institutions to prove the therapeutic efficacy of neuro-monitoring systems is another significant factor that is expected to bolster the market.
The easy availability of favourable medical reimbursement policies in China, Japan, India, and South Korea is projected to foster the Asia Pacific neuro monitoring system market growth in future years. The increasing awareness among healthcare professionals about various clinical benefits related to nerve monitoring is anticipated to boost the regional market.
Furthermore, the growing usage of intraoperative nerve monitoring systems during various surgeries and ongoing technological advancements in the field of nerve stimulation is expected to aid growth. An increasing number of surgical centres and hospitals across the Asia Pacific owing to rising investments by governments is another vital factor that is set to drive the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the leading companies present in the global neuro monitoring system market include NuVasive Inc., Inomed Medizintechnik GmbH, AXIS Neuromonitoring, LLC, Accurate Monitoring, SpecialityCare, Medtronic, Biotronic NeuroNetwork Sentient Medical Systems, Natus Medical Incorporated, and Neuromonitoring Technologies among others.
The global market is highly competitive with the presence of a large number of key players. The majority of these companies are engaging in mergers and acquisitions with local enterprises to co-develop innovative products and attract more customers. A few other companies in the market are striving to expand their portfolios by introducing novel products and surging sales of neuro-monitoring systems.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 6.8% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
The global neuro monitoring system market is likely to exceed US$ 9.4 Billion in 2032.
North America is set to lead the neuro monitoring system market in the forecast period.
NuVasive Inc., Inomed Medizintechnik GmbH, AXIS Neuromonitoring, LLC, Accurate Monitoring, SpecialityCare, and Medtronic are some of the renowned companies in the neuro monitoring system market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Neuro-monitoring System Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Neuro-monitoring System Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product Type, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product Type, 2022-2032 5.3.1. Instruments 5.3.2. Nerve Stimulation Electrodes and Probes 5.3.3. Accessories 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021 5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032 Deep-dive segmentation will be available in the sample on request 6. Global Neuro-monitoring System Market Analysis 2017-2021 and Forecast 2022-2032, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Application, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Application, 2022-2032 6.3.1. Functional Neurosurgery 6.3.2. Carotid Endarterectomy 6.3.3. Epilepsy Surgery 6.3.4. Stereotactic Surgery 6.3.5. Carotid Endarterectomy 6.3.6. Pelvic Fracture Surgery 6.3.7. Vestibular Nerve Section 6.3.8. Orbital Surgery 6.3.9. Others 6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021 6.5. Absolute $ Opportunity Analysis By Application, 2022-2032 Deep-dive segmentation will be available in the sample on request 7. Global Neuro-monitoring System Market Analysis 2017-2021 and Forecast 2022-2032, By Technology 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Technology, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Technology, 2022-2032 7.3.1. Motor-Sensory Evoked Potentials 7.3.2. Sub-Sensory Evoked Potentials 7.3.3. Mapping for Motor-Cortex 7.3.4. Electromyography (EMG) 7.3.5. Electroencephalography (EEG) 7.4. Y-o-Y Growth Trend Analysis By Technology, 2017-2021 7.5. Absolute $ Opportunity Analysis By Technology, 2022-2032 Deep-dive segmentation will be available in the sample on request 8. Global Neuro-monitoring System Market Analysis 2017-2021 and Forecast 2022-2032, By End Users 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End Users, 2017-2021 8.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End Users, 2022-2032 8.3.1. Hospitals 8.3.2. Ambulatory Surgical Centers 8.3.3. Diagnostic Centers 8.3.4. Neonatal Intensive Care Value (US$ Mn) & Volume (Units) 8.3.5. Intensive Care Value (US$ Mn) & Volume (Units) 8.3.6. Specialized Clinics 8.4. Y-o-Y Growth Trend Analysis By End Users, 2017-2021 8.5. Absolute $ Opportunity Analysis By End Users, 2022-2032 Deep-dive segmentation will be available in the sample on request 9. Global Neuro-monitoring System Market Analysis 2017-2021 and Forecast 2022-2032, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021 9.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. East Asia 9.3.5. South Asia & Pacific 9.3.6. MEA 9.4. Market Attractiveness Analysis By Region 10. North America Neuro-monitoring System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. U.S. 10.2.1.2. Canada 10.2.2. By Product Type 10.2.3. By Application 10.2.4. By Technology 10.2.5. By End Users 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Application 10.3.4. By Technology 10.3.5. By End Users 10.4. Key Takeaways 11. Latin America Neuro-monitoring System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Product Type 11.2.3. By Application 11.2.4. By Technology 11.2.5. By End Users 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Application 11.3.4. By Technology 11.3.5. By End Users 11.4. Key Takeaways 12. Europe Neuro-monitoring System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. U.K. 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Europe 12.2.2. By Product Type 12.2.3. By Application 12.2.4. By Technology 12.2.5. By End Users 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Application 12.3.4. By Technology 12.3.5. By End Users 12.4. Key Takeaways 13. East Asia Neuro-monitoring System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Product Type 13.2.3. By Application 13.2.4. By Technology 13.2.5. By End Users 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Application 13.3.4. By Technology 13.3.5. By End Users 13.4. Key Takeaways 14. South Asia & Pacific Neuro-monitoring System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 14.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 14.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 14.2.1. By Country 14.2.1.1. India 14.2.1.2. Thailand 14.2.1.3. Indonesia 14.2.1.4. Malaysia 14.2.1.5. Singapore 14.2.1.6. Australia 14.2.1.7. New Zealand 14.2.1.8. Rest of South Asia & Pacific 14.2.2. By Product Type 14.2.3. By Application 14.2.4. By Technology 14.2.5. By End Users 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Application 14.3.4. By Technology 14.3.5. By End Users 14.4. Key Takeaways 15. MEA Neuro-monitoring System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 15.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 15.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Product Type 15.2.3. By Application 15.2.4. By Technology 15.2.5. By End Users 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Application 15.3.4. By Technology 15.3.5. By End Users 15.4. Key Takeaways 16. Key Countries Neuro-monitoring System Market Analysis 16.1. U.S. 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2021 16.1.2.1. By Product Type 16.1.2.2. By Application 16.1.2.3. By Technology 16.1.2.4. By End Users 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2021 16.2.2.1. By Product Type 16.2.2.2. By Application 16.2.2.3. By Technology 16.2.2.4. By End Users 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2021 16.3.2.1. By Product Type 16.3.2.2. By Application 16.3.2.3. By Technology 16.3.2.4. By End Users 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2021 16.4.2.1. By Product Type 16.4.2.2. By Application 16.4.2.3. By Technology 16.4.2.4. By End Users 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2021 16.5.2.1. By Product Type 16.5.2.2. By Application 16.5.2.3. By Technology 16.5.2.4. By End Users 16.6. U.K. 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2021 16.6.2.1. By Product Type 16.6.2.2. By Application 16.6.2.3. By Technology 16.6.2.4. By End Users 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2021 16.7.2.1. By Product Type 16.7.2.2. By Application 16.7.2.3. By Technology 16.7.2.4. By End Users 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2021 16.8.2.1. By Product Type 16.8.2.2. By Application 16.8.2.3. By Technology 16.8.2.4. By End Users 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2021 16.9.2.1. By Product Type 16.9.2.2. By Application 16.9.2.3. By Technology 16.9.2.4. By End Users 16.10. China 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2021 16.10.2.1. By Product Type 16.10.2.2. By Application 16.10.2.3. By Technology 16.10.2.4. By End Users 16.11. Japan 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2021 16.11.2.1. By Product Type 16.11.2.2. By Application 16.11.2.3. By Technology 16.11.2.4. By End Users 16.12. South Korea 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2021 16.12.2.1. By Product Type 16.12.2.2. By Application 16.12.2.3. By Technology 16.12.2.4. By End Users 16.13. India 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2021 16.13.2.1. By Product Type 16.13.2.2. By Application 16.13.2.3. By Technology 16.13.2.4. By End Users 16.14. Thailand 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2021 16.14.2.1. By Product Type 16.14.2.2. By Application 16.14.2.3. By Technology 16.14.2.4. By End Users 16.15. Indonesia 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2021 16.15.2.1. By Product Type 16.15.2.2. By Application 16.15.2.3. By Technology 16.15.2.4. By End Users 16.16. Malaysia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2021 16.16.2.1. By Product Type 16.16.2.2. By Application 16.16.2.3. By Technology 16.16.2.4. By End Users 16.17. Singapore 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2021 16.17.2.1. By Product Type 16.17.2.2. By Application 16.17.2.3. By Technology 16.17.2.4. By End Users 16.18. Australia 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2021 16.18.2.1. By Product Type 16.18.2.2. By Application 16.18.2.3. By Technology 16.18.2.4. By End Users 16.19. New Zealand 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2021 16.19.2.1. By Product Type 16.19.2.2. By Application 16.19.2.3. By Technology 16.19.2.4. By End Users 16.20. GCC Countries 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2021 16.20.2.1. By Product Type 16.20.2.2. By Application 16.20.2.3. By Technology 16.20.2.4. By End Users 16.21. South Africa 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2021 16.21.2.1. By Product Type 16.21.2.2. By Application 16.21.2.3. By Technology 16.21.2.4. By End Users 16.22. Israel 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2021 16.22.2.1. By Product Type 16.22.2.2. By Application 16.22.2.3. By Technology 16.22.2.4. By End Users 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product Type 17.3.3. By Application 17.3.4. By Technology 17.3.5. By End Users 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Neurosoft 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. Cadwell Industries 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. Dr. Langer Medical 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. Medizintechnik 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Mdoloris Medical Systems 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. Neurosign 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. Neurosoft 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. Nihon Kohden Corporation 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. Recorders & Medicare Systems P Ltd. 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 18.1.10. Medicaid Systems 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.10.5.2. Product Strategy 18.1.10.5.3. Channel Strategy 18.1.11. EB Neuro S.p.A. 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.11.5.2. Product Strategy 18.1.11.5.3. Channel Strategy 18.1.12. Natus Medical Incorporated 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.12.5.2. Product Strategy 18.1.12.5.3. Channel Strategy 18.1.13. Medtronic 18.1.13.1. Overview 18.1.13.2. Product Portfolio 18.1.13.3. Profitability by Market Segments 18.1.13.4. Sales Footprint 18.1.13.5. Strategy Overview 18.1.13.5.1. Marketing Strategy 18.1.13.5.2. Product Strategy 18.1.13.5.3. Channel Strategy 18.1.14. NuVasive 18.1.14.1. Overview 18.1.14.2. Product Portfolio 18.1.14.3. Profitability by Market Segments 18.1.14.4. Sales Footprint 18.1.14.5. Strategy Overview 18.1.14.5.1. Marketing Strategy 18.1.14.5.2. Product Strategy 18.1.14.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Healthcare
February 2022
REP-GB-575
May 2024
250 pages
Explore Healthcare Insights
View Reports
Neuro-monitoring System Market
